The association between HLA-B variants and amoxicillin-induced severe cutaneous adverse reactions in Chinese han

Ting Wang1, Jin Yang2,3,4, Fanping Yang2,3,4

  • 1Children's Hospital of Fudan University, Institutes of Biomedical Sciences of Fudan, Shanghai, China.

PubMed
Abstract

Insights

Genetic factors, specifically HLA-B*15:01, are strongly associated with amoxicillin-induced severe cutaneous adverse reactions (AMX-SCAR). This discovery may help identify individuals at risk for AMX-SCAR and guide safer antibiotic prescribing.

Area of Science:

  • Pharmacogenomics
  • Immunogenetics
  • Dermatology

Background:

  • Amoxicillin (AMX) is a widely used antibiotic with a generally good safety profile.
  • Severe cutaneous adverse reactions (SCAR) to AMX, though rare, carry significant morbidity and mortality.
  • The genetic underpinnings of AMX-SCAR are not well understood, hindering personalized risk assessment.

Purpose of the Study:

  • To identify genetic risk factors associated with amoxicillin-induced severe cutaneous adverse reactions (AMX-SCAR).
  • To investigate the role of Human Leukocyte Antigen (HLA) genes in AMX-SCAR susceptibility.
  • To explore the molecular mechanisms of AMX-SCAR through computational analysis.

Main Methods:

  • Case-control study involving four AMX-SCAR patients, 1,000 population controls, and 100 AMX-tolerant individuals.
  • Exome-wide and HLA-specific association studies were performed.
  • Molecular docking simulations were used to analyze drug-protein interactions.

Main Results:

  • A significant association was found between HLA-B*15:01 and AMX-SCAR (OR=22.9, p=7.34 × 10^-3).
  • The S140 epitope within the HLA-B protein showed a strong association with AMX-SCAR (OR=53.5, p=5.18 × 10^-4).
  • Molecular docking confirmed direct interaction between AMX and the HLA-B S140 epitope.

Conclusions:

  • Genetic susceptibility, particularly involving HLA-B variants, plays a role in AMX-SCAR development in the Han Chinese population.
  • HLA-B*15:01 may serve as a potential genetic marker for predicting AMX-SCAR risk.
  • Further validation in larger, diverse populations is warranted to confirm these findings and their clinical utility.

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
31.0K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
833
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
601
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
485
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.3K